(CRML) Critical Metals Ordinary - Overview
Stock: Lithium, Rare Earth Elements
| Risk 5d forecast | |
|---|---|
| Volatility | 204% |
| Relative Tail Risk | -19.7% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.19 |
| Alpha | 9.45 |
| Character TTM | |
|---|---|
| Beta | 1.116 |
| Beta Downside | 0.859 |
| Drawdowns 3y | |
|---|---|
| Max DD | 93.91% |
| CAGR/Max DD | 0.02 |
Description: CRML Critical Metals Ordinary December 29, 2025
Critical Metals Corp. (NASDAQ: CRML) is a mining exploration and development firm focused on lithium and rare-earth element projects in Austria and southern Greenland. The company is incorporated in the British Virgin Islands and operates as a subsidiary of European Lithium Limited.
Key sector drivers include the rapid expansion of electric-vehicle (EV) production, which is projected to boost global lithium demand at a CAGR of roughly 14 % through 2030, and the growing need for rare-earths in clean-energy technologies such as wind turbines and high-efficiency magnets. CRML’s primary assets lie in the Zinnwald lithium-bearing pegmatites in Austria and the Kvanefjeld rare-earth project in Greenland, both positioned to benefit from Europe’s strategic push for domestic critical-metal supply chains.
Recent market data shows CRML trading at a market-cap of about $70 million, with a cash-on-hand balance of roughly $12 million as of the latest filing, providing runway for continued drilling and permitting activities. The company’s progress is closely tied to European Lithium’s joint-venture partnership with the Icelandic firm Icelandic Strategic Energy Fund, which could unlock additional funding contingent on resource delineation milestones.
For a deeper dive into CRML’s valuation metrics and risk profile, the ValueRay profile offers a concise, data-driven analysis.
Piotroski VR‑10 (Strict, 0-10) 0.0
| Net Income: -51.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.09 > 0.02 and ΔFCF/TA -3.79 > 1.0 |
| NWC/Revenue: -10.1k% < 20% (prev -96.7k%; Δ 86.6k% < -1%) |
| CFO/TA -0.08 > 3% & CFO -14.5m > Net Income -51.9m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 0.13 > 1.5 & < 3 |
| Outstanding Shares: last quarter (97.4m) vs 12m ago 10.22% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 0.35% > 50% (prev 0.04%; Δ 0.31% > 0%) |
| Interest Coverage Ratio: -94.81 > 6 (EBITDA TTM -47.5m / Interest Expense TTM 500.7k) |
Altman Z'' -9.36
| A: -0.33 (Total Current Assets 8.31m - Total Current Liabilities 64.8m) / Total Assets 171.7m |
| B: -1.17 (Retained Earnings -200.6m / Total Assets 171.7m) |
| C: -0.30 (EBIT TTM -47.5m / Avg Total Assets 159.0m) |
| D: -1.32 (Book Value of Equity -105.7m / Total Liabilities 79.8m) |
| Altman-Z'' Score: -9.36 = D |
Beneish M 1.00
| DSRI: 0.01 (Receivables 47.9k/837.9k, Revenue 560.6k/59.1k) |
| GMI: 0.57 (GM 97.99% / 56.01%) |
| AQI: 0.95 (AQ_t 0.72 / AQ_t-1 0.76) |
| SGI: 9.49 (Revenue 560.6k / 59.1k) |
| TATA: -0.22 (NI -51.9m - CFO -14.5m) / TA 171.7m) |
| Beneish M-Score: 1.60 (Cap -4..+1) = D |
What is the price of CRML shares?
Over the past week, the price has changed by -16.29%, over one month by -6.65%, over three months by +9.48% and over the past year by +91.74%.
Is CRML a buy, sell or hold?
What are the forecasts/targets for the CRML price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 13.4 | 21.7% |
CRML Fundamental Data Overview February 04, 2026
P/B = 16.886
Revenue TTM = 560.6k USD
EBIT TTM = -47.5m USD
EBITDA TTM = -47.5m USD
Long Term Debt = 14.2k USD (estimated: total debt 5.88m - short term 5.87m)
Short Term Debt = 5.87m USD (from shortTermDebt, last quarter)
Debt = 5.88m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.42m USD (from netDebt column, last quarter)
Enterprise Value = 1.48b USD (1.48b + Debt 5.88m - CCE 7.30m)
Interest Coverage Ratio = -94.81 (Ebit TTM -47.5m / Interest Expense TTM 500.7k)
EV/FCF = -95.44x (Enterprise Value 1.48b / FCF TTM -15.5m)
FCF Yield = -1.05% (FCF TTM -15.5m / Enterprise Value 1.48b)
FCF Margin = -2772 % (FCF TTM -15.5m / Revenue TTM 560.6k)
Net Margin = -9253 % (Net Income TTM -51.9m / Revenue TTM 560.6k)
Gross Margin = unknown ((Revenue TTM 560.6k - Cost of Revenue TTM 11.2k) / Revenue TTM)
Tobins Q-Ratio = 8.64 (Enterprise Value 1.48b / Total Assets 171.7m)
Interest Expense / Debt = 8.51% (Interest Expense 500.7k / Debt 5.88m)
Taxrate = 21.0% (US default 21%)
NOPAT = -37.5m (EBIT -47.5m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.13 (Total Current Assets 8.31m / Total Current Liabilities 64.8m)
Debt / Equity = 0.06 (Debt 5.88m / totalStockholderEquity, last quarter 91.9m)
Debt / EBITDA = 0.03 (negative EBITDA) (Net Debt -1.42m / EBITDA -47.5m)
Debt / FCF = 0.09 (negative FCF - burning cash) (Net Debt -1.42m / FCF TTM -15.5m)
Total Stockholder Equity = 82.8m (last 4 quarters mean from totalStockholderEquity)
RoA = -32.62% (Net Income -51.9m / Total Assets 171.7m)
RoE = -62.67% (Net Income TTM -51.9m / Total Stockholder Equity 82.8m)
RoCE = -57.34% (EBIT -47.5m / Capital Employed (Equity 82.8m + L.T.Debt 14.2k))
RoIC = -41.54% (negative operating profit) (NOPAT -37.5m / Invested Capital 90.3m)
WACC = 10.02% (E(1.48b)/V(1.49b) * Re(10.03%) + D(5.88m)/V(1.49b) * Rd(8.51%) * (1-Tc(0.21)))
Discount Rate = 10.03% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 213.6%
Fair Price DCF = unknown (Cash Flow -15.5m)
EPS Correlation: -61.01 | EPS CAGR: -91.93% | SUE: N/A | # QB: 0
Revenue Correlation: 65.51 | Revenue CAGR: 0.0% | SUE: N/A | # QB: 0